93Chabot S, Orio J, Schmeer M, Schleef M, Golzio M, Teissie J (2013) Minicircle DNA electrotrans-
fer for effi cient tissue-targeted gene delivery. Gene Ther 20:62–68
Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L (2009) Highly
effi cient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling.
Nat Biotechnol 27:275–280
Chang MY, Kim D, Kim CH, Kang HC, Yang E, Moon JI, Ko S, Park J, Park KS, Lee KA et al
(2010) Direct reprogramming of rat neural precursor cells and fi broblasts into pluripotent stem
cells. PLoS One 5, e9838
Chen G, Gulbranson DR, Hou Z, Bolin JM, Ruotti V, Probasco MD, Smuga-Otto K, Howden SE,
Diol NR, Propson NE et al (2011) Chemically defi ned conditions for human iPSC derivation
and culture. Nat Methods 8:424–429
Chen YF, Tseng CY, Wang HW, Kuo HC, Yang VW, Lee OK (2012) Rapid generation of mature
hepatocyte-like cells from human induced pluripotent stem cells by an effi cient three-step pro-
tocol. Hepatology 55:1193–1203
Cherry AB, Daley GQ (2013) Reprogrammed cells for disease modeling and regenerative medi-
cine. Annu Rev Med 64:277–290
Chetty S, Pagliuca FW, Honore C, Kweudjeu A, Rezania A, Melton DA (2013) A simple tool to
improve pluripotent stem cell differentiation. Nat Methods 10:553–556
Choi KD, Yu J, Smuga-Otto K, Salvagiotto G, Rehrauer W et al (2009) Hematopoietic and endo-
thelial differentiation of human induced pluripotent stem cells. Stem Cells 27:559–567
Choi SM, Kim Y, Shim JS, Park JT, Wang RH, Leach SD, Liu JO, Deng C, Ye Z, Jang YY (2013)
Effi cient drug screening and gene correction for treating liver disease using patient-specifi c
stem cells. Hepatology 57:2458–2468
Muratore CR, Srikanth P, Callahan DG, Young-Pearse TL (2014) Comparison and optimization of
hiPSC forebrain cortical differentiation protocols. PLoS One 9, e105807
Chun YS, Chaudhari P, Jang YY (2010) Applications of patient-specifi c induced pluripotent stem
cells; focused on disease modeling, drug screening and therapeutic potentials for liver disease.
Int J Biol Sci 6:796–805
Davis RL, Weintraub H, Lassar AB (1987) Expression of a single transfected cDNA converts
fi broblasts to myoblasts. Cell 51:987–1000
Deng Y, Liu Q, Luo C, Chen S, Li X, Wang C, Liu Z, Lei X, Zhang H, Sun H et al (2012) Generation
of induced pluripotent stem cells from buffalo ( Bubalus bubalis ) fetal fi broblasts with buffalo
defi ned factors. Stem Cells Dev 21:2485–2494
Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft GF, Saphier
G, Leibel R, Goland R et al (2008) Induced pluripotent stem cells generated from patients with
ALS can be differentiated into motor neurons. Science 321:1218–1221
Draper JS, Moore HD, Ruban LN, Gokhale PJ, Andrews PW (2004) Culture and characterization
of human embryonic stem cells. Stem Cells Dev 13:325–336
Ebert AD, Liang P, Wu JC (2012) Induced pluripotent stem cells as a disease modeling and drug
screening platform. J Cardiovasc Pharmacol 60:408–416
Ebert AD, Yu J, Rose FF Jr, Mattis VB, Lorson CL, Thomson JA, Svendsen CN (2009) Induced
pluripotent stem cells from a spinal muscular atrophy patient. Nature (Lond) 457:277–280
Egawa N, Kitaoka S, Tsukita K, Naitoh M, Takahashi K, Yamamoto T, Adachi F, Kondo T, Okita
K, Asaka I et al (2012) Drug screening for ALS using patient-specifi c induced pluripotent stem
cells. Sci Transl Med 4:145ra104
Egusa H, Okita K, Kayashima H, Yu G, Fukuyasu S, Saeki M, Matsumoto T, Yamanaka S, Yatani
H (2010) Gingival fi broblasts as a promising source of induced pluripotent stem cells. PLoS
One 5, e12743
Esteban MA, Xu J, Yang J, Peng M, Qin D, Li W, Jiang Z, Chen J, Deng K, Zhong M et al (2009)
Generation of induced pluripotent stem cell lines from Tibetan miniature pig. J Biol Chem
284:17634–17640
Evans MJ, Kaufman MH (1981) Establishment in culture of pluripotential cells from mouse
embryos. Nature (Lond) 292:154–156
4 New Trends in Clinical Applications of Induced Pluripotent Stem Cells